Clinical Trials
All Clinical Trials - Page 22 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05394519Phase 3Completed
A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight
Semaglutide
- NCT05610124N/AUnknown
Postprandial Glycemia and Satiety of Meals With Potatoes, With and Without Protein
Ghrp-6
- NCT07340437N/ACompleted
Clinical Study of 18F-Exendin-4 in Insulinoma
Exenatide
- NCT05605964Phase 3Completed
Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate
Gonadorelin
- NCT06607666N/ACompleted
Acromegaly Resistant to Conventional Dose of First Generation Somatostatin Ligands
Lanreotide
- NCT05579249Phase 4Completed
A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
Semaglutide
- NCT05671653Phase 1Terminated
A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range
Semaglutide
- NCT05669599Phase 2Completed
Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus
Maridebart-Cafraglutide
- NCT05689099Phase 1Completed
A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose
Semaglutide
- NCT05720260Phase 2Recruiting
Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC
Gonadorelin
- NCT05705388N/AUnknown
POSE2.0 With GLP-1 Agonist for Obesity Management
Liraglutide
- NCT04915144Phase 2Withdrawn
177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs
Octreotide
- NCT05700877Phase 4Recruiting
Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes
Semaglutide
- NCT05680129Phase 3Completed
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM
Dulaglutide
- NCT05606913Phase 3Completed
A Study of IBI362 in Participants With Type 2 Diabetes
Dulaglutide
- NCT05628311Phase 3Completed
A Study of IBI362 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise
Mazdutide
- NCT05649137Phase 3Completed
A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight
Semaglutide
- NCT06868576Phase 3Completed
PPOS Protocol Versus GnRH Anatagonist for Expected Normal Responder Patients Undergoing ART : a Randomized Clinical Trial
Gonadorelin
- NCT05597202Phase 4Unknown
Does the Hematopoietic Stem Cell Govern Residual Inflammatory Cardiovascular Risk in Type 2 Diabetes
Semaglutide
- NCT07674290Phase 4Recruiting
Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity
Setmelanotide
- NCT05594095Phase 2Recruiting
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
Gonadorelin
- NCT05659537Phase 4Completed
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India
Dulaglutide
- NCT05652205Phase 3Completed
A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional Constipation
Linaclotide
- NCT05709444Phase 2Completed
A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease
PT-141
- NCT05749289Phase 2/Phase 3Recruiting
Application of Al18F-octreotide PET/CT in Tumors With Positive SSTR Expression
Octreotide
- NCT06201819Phase 4Completed
Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery
Liraglutide
- NCT05633966Phase 1Completed
Kisspeptin Administration Subcutaneously to Patients With Reproductive Disorders
Kisspeptin
- NCT05087342Phase 3Completed
Latino Semaglutide Study
Semaglutide
- NCT04589819Phase 4Enrolling By Invitation
Fracture Recovery for Returning to Duty (Teriparatide STRONG)
Teriparatide
- NCT05610800Phase 2Completed
Exenatide for Smoking Cessation and Prevention of Weight Gain
Exenatide
- NCT05616052Phase 4Unknown
Comparison of Body Weight Change Through Different Smeglutide Administration Methods
Semaglutide
- NCT05767255Phase 3Unknown
Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue
Liraglutide
- NCT06185361N/AUnknown
Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.
Desmopressin
- NCT05564039Phase 4Completed
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)
Tirzepatide
- NCT05768945N/ACompleted
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors
Semaglutide
- NCT05107219Phase 1Completed
GCC Agonist Signal in the Small Intestine
Linaclotide
- NCT06217848EARLY_Phase 1Unknown
The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study
Liraglutide
- NCT05598008N/ACompleted
Effects of Glucagon-like-Peptide-1 Analogues on Sexuality
Liraglutide
- NCT05617664N/AUnknown
Mirabegron 25 mg for Treatment of Primary Nocturnal Enuresis
Desmopressin
- NCT05347147Phase 3Terminated
A Trial to Determine the Efficacy and Safety of Presendin in IIH
Exenatide
- NCT05590793Phase 3Completed
Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate
Gonadorelin
- NCT05611957Phase 1Completed
A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function
Retatrutide
- NCT05623839Phase 1Completed
A Study of LY3305677 in Participants With Obesity Or Overweight
Mazdutide
- NCT05607680Phase 3Completed
A Study of IBI362 in Participants With Obesity or Overweight
Mazdutide
- NCT05582096Phase 1Completed
A Study of LY3457263 in Obese Participants
Tirzepatide
- NCT05613387Phase 1Completed
A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy Participants
Petrelintide
- NCT05567796Phase 3Active Not Recruiting
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
Semaglutide
- NCT05073835Phase 3Active Not Recruiting
Semaglutide 2.4 mg in Patients With Poor Weight-loss
Semaglutide
- NCT05582499Phase 2Recruiting
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
Gonadorelin
- NCT04616729Phase 1/Phase 2Unknown
DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation
Gonadorelin